Abstracts must be comprised of four distinct sections:

• Introduction: Describes previous research and the rationale for the current study
• Method: Describes how the study was conducted
• Results: Describes the results of the study
• Conclusion: Summarize the study and discusses its implications

All abstracts must be submitted electronically through the Meeting management system.

• Abstracts should be submitted only in English.
• There is no fee for submission
• The abstract text body is limited to 250 words, not including title or authors or institutions.
• 1 table or figure (in JPG, GIF or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups. File size of 2 MB maximum for each figure. Make sure you submit your figure with no surrounding white space and the text is readable.
• It is the submitter’s responsibility to ensure that all co-authors approve of the abstract submission, publication, and potential presentation.
• There will be some awards, abstracts submitters will be able to apply for, we will share more information on awards by the time abstract submission opens.

Notification of acceptance or rejection will be sent to the submitting (corresponding) author by September 4, 2023. Please note that only the corresponding author will receive the communication concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.

Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

The Summit welcomes the submission of abstracts previously presented at national, regional or international meetings in the two years preceding the congress. Encores must be documented as such at the time of submission. To be accepted, the abstract must include significant additional data from the previous presentation/s. Submission will not be permitted if a manuscript has been published.

The Summit regards plagiarism as serious professional misconduct. All abstracts are screened for plagiarism and when identified, the abstract and any other abstracts submitted by the same author will be rejected. In addition, the submitting author’s profile and award application, in the case one has been submitted, will also be cancelled.

To be eligible to submit an abstract, you must disclose that the author(s)/ scientist(s) have not violated any aspect of the following Ethics Statement:

• Declaration of Istanbul (DOI) ethics' statement 
• Research conforms with the ethical statement on human research subject, Helsinki Declaration of The World Medical Association
• The Ethics of Xenotransplantation (Xenotransplantation 10:194-203, 2003) For research involving human subjects -The Helsinki. 
• The Transplantation Society Ethics statement